China Regenerative Medicine International Limited

SEHK:8158 Stock Report

Market Cap: HK$130.8m

China Regenerative Medicine International Dividends and Buybacks

Dividend criteria checks 0/6

China Regenerative Medicine International does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

Mar 05
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

Jan 04
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

Sep 21
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Jun 11
China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

May 22
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Apr 13
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Sep 22
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

Mar 16
Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Feb 08
What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Dec 15
Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Nov 25
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Nov 24
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 8158's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 8158's dividend payments have been increasing.


Dividend Yield vs Market

China Regenerative Medicine International Dividend Yield vs Market
How does 8158 dividend yield compare to the market?
SegmentDividend Yield
Company (8158)n/a
Market Bottom 25% (HK)3.0%
Market Top 25% (HK)7.9%
Industry Average (Biotechs)1.0%
Analyst forecast (8158) (up to 3 years)n/a

Notable Dividend: Unable to evaluate 8158's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 8158's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 8158's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 8158 has not reported any payouts.


Discover strong dividend paying companies